文献速递妇科产科

晚期卵巢癌完全肉眼切除后胸腔复发:隐匿性膈下淋巴管侵犯的临床影响

Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion.
PubMed 文献 · Gynecol Oncol · 2026-10-31

50.0%患者检出膈下淋巴管侵犯,其胸腔复发率显著更高(43.2% vs. 10.8%),且为胸腔复发的独立预测因素(sHR 16.5,95%CI 5.1-53.9,p<0.001)。

要点

  • 完全肉眼切除的晚期卵巢癌中,50.0%存在膈下淋巴管侵犯。
  • 膈下淋巴管侵犯者胸腔复发率43.2%,无侵犯者10.8%。
  • 膈下淋巴管侵犯独立预测胸腔复发(sHR 16.5,p<0.001)。

核心结论

  • 膈下淋巴管侵犯与晚期卵巢癌完全肉眼切除后胸腔复发独立相关,支持经膈肿瘤播散途径。

研究设计与样本

  • 采用D2-40和CD31免疫组化显微镜下评估膈下区域淋巴血管侵犯。
  • 胸腔复发采用Fine-Gray模型分析。

主要发现

  • 膈下淋巴管侵犯检出37例(50.0%),其中7例无宏观病灶;静脉侵犯仅1例。
  • 中位随访30.9个月,胸腔复发20例(27.0%),腹腔复发18例(24.3%)。
  • 膈下淋巴管侵犯者胸腔复发率43.2%,无侵犯者10.8%。
  • 膈下淋巴管侵犯独立预测胸腔复发(sHR 16.5,95%CI 5.1-53.9,p<0.001)。

临床怎么用

  • 对完全肉眼切除的晚期卵巢癌患者,应关注膈下淋巴管侵犯的病理评估。
  • 检出膈下淋巴管侵犯者需警惕胸腔复发,可能需加强胸部监测。

局限性

  • 随访时间中位30.9个月,可能不足以捕捉全部复发事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Complete gross tumor resection is an important prognostic factor in advanced ovarian cancer (AOC), and total parietal peritonectomy (TPP) is a key method to achieve it. Despite undergoing complete gross resection, some patients experience thoracic recurrence, which is associated with a poor prognosis. Clinicopathological factors associated with such recurrence remain unclear. We hypothesized that occult lymphovascular invasion within the subdiaphragmatic peritoneum, the lymphatic interface between the peritoneal and thoracic cavities, may be associated with thoracic recurrence. METHODS: We retrospectively analyzed patients with International Federation of Gynecology and Obstetrics stage IIIB-IVB ovarian cancer who underwent complete resection using TPP. Clinicopathological factors evaluated were stage, neoadjuvant chemotherapy, homologous recombination deficiency status, and intraoperative macroscopic findings. The subdiaphragmatic regions were microscopically assessed for lymphovascular invasion using D2-40 and CD31 immunohistochemistry. Thoracic recurrence was analyzed using Fine-Gray model. RESULTS: Seventy-four patients were included: 47 (63.5%) and 27 (36.5%) had stage III and IV disease, respectively. Neoadjuvant chemotherapy was administered to 38 (51.4%) patients. Subdiaphragmatic lymphatic invasion (SLI) was detected in 37 patients (50.0%), including seven without macroscopic lesions; venous invasion was rare (n = 1). During a median follow-up of 30.9 months, 20 (27.0%) and 18 (24.3%) patients developed thoracic and abdominal recurrence, respectively. Thoracic recurrence was significantly higher with SLI (43.2% vs. 10.8%); SLI independently predicted thoracic recurrence (subdistribution hazard ratios, 16.5, 95% confidence interval, 5.1-53.9; p < 0.001). CONCLUSIONS: SLI was independently associated with thoracic recurrence after complete gross resection in AOC, supporting a potential transdiaphragmatic pathway of tumor dissemination.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Onishi J, Nagamine M, Wakabayashi M, et al. Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion. Gynecol Oncol. 2026. PMID: 42966332. doi:10.1016/j.ygyno.2026.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。